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BACKGROUND
Though the total number of individuals with hemoglobinopathies in 
Georgia is uncertain, it is known that Georgia ranks among the top states 
in sickle cell disease prevalence. Estimates range from as low as 4,981 to 
as high as 8,427. Along with six other states, Georgia participated in the 
two-year Registry and Surveillance System for Hemoglobinopathies 
(RuSH) pilot project. Objectives: To determine the annual incidence and 
ve-year prevalence (2004-2008) of hemoglobinopathies in Georgia and 
to describe the demographics of the populations living with these 
disorders.
METHODS
Potential cases are identied from ve sources: (1) the state newborn 
screening program (NBS); (2) the Georgia hospital discharge le, which 
includes most in-patient and emergency room visits in the state; (3) the 
Grady, CHOA and GHSU health systems, including all outpatient visits; (4) 
the State Medicaid and CHIP programs; and (5) the State Health Benet 
Plan (SHBP).  Laboratory screening and conrmatory results, coupled with 
clinical expertise, are used to conrm cases from NBS, Grady and GHSU 
data. ICD-9 and CPT codes are used to identify probable and possible 
cases from additional administrative datasets. Individual datasets are 
examined to produce preliminary geographic estimates of prevalence 
and to judge the potential overlap of cases prior to merging all datasets 
into one surveillance system.
Figure 1: Georgia RuSH project case-nding data sets
RESULTS
From 2004 through 2008, 1,009 newborns screened positive for a 
hemoglobin disorder in Georgia.  During that same time period, CHOA 
treated approximately 2,580 pediatric patients with a hemoglobin disorder, 
and Grady and GHSU treated approximately 1,600 and 1,450 patients, 
respectively.  Medicaid and CHIP programs paid claims for approximately 
14,667 enrollees with a hemoglobinopathy-associated medical encounter, 
while the SHBP covered such services for 1,737 enrollees. Lastly, close to 
9,778 individuals were treated in a Georgia emergency room or hospital for a 
hemoglobinopathy. (Figure 1)  We estimate that up to 47 percent of the 
9,778 individuals identied through state hospital discharge data may also 
be present in one of the three hospital systems’ data.  (Figure 2)
Figure 2: Clinic Patient/Hospital Discharge Count Overlap, 
2004-2008
As well, 55 percent of the Medicaid/CHIP patients and 32 percent of the 
SHBP patients likely overlap with the hospital discharge le.  However, 88 
percent of Medicaid enrollees and 70 percent of SHBP enrollees ever coded 
with a hemoglobinopathy had a hospitalization or ER visit from 2004 to 
2008. (Figure 3)
Figure 3:  Overlap between Health Insurance Claims data 
and Georgia Hospital Discharge Data
Close to 90 percent of the newborns identied through NBS are estimated to 
be followed by one of the three hospital systems.  
Using newborn screening data from 2004 through 2008 (Figure 4), we 
identied the counties with the highest number of incident cases.  Most cases 
are found in the ve metro Atlanta counties (Fulton, DeKalb, Cobb, Gwinnett 
and Clayton) as well as the smaller metropolitan areas in South and 
Southeastern Georgia.  
Figure 4: Georgia newborns screening positive for sickle cell 
disease, January 2004 through December 2008 
CONCLUSION AND IMPLICATIONS 
Early outcomes from the Georgia RuSH project have allowed us to identify 
areas of the state to focus hemoglobinopathy outreach eorts. Further 
progress will allow us to answer programmatic, policy and outreach questions 
specic to Georgia, and aid the development of educational materials for 
providers, policy-makers and legislators. Lessons learned can be shared with 
other states interested in developing hemoglobinopathy surveillance systems.  
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